Oxnard, CA, United States of America

Anthony Trieu

This inventor holds 1 USPTO granted patent. Top assignee: Dow Agrosciences LLC. Active years: 2007.


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anthony Trieu: Innovator in Plant Disease Resistance

Introduction

Anthony Trieu is a notable inventor based in Oxnard, California. He has made significant contributions to the field of agricultural biotechnology, particularly in developing solutions for plant disease resistance. His work focuses on identifying and isolating genes that can enhance disease control properties in plants.

Latest Patents

Anthony Trieu holds 1 patent for his invention titled "Nucleic acid compositions conferring disease resistance." This patent encompasses the identification and isolation of genes derived from various sources, including var. Indica IR7, Papaver rhoeas, and Rifai 1295-22. The invention aims to confer control against phytopathogens such as Cercospora zeae-maydis. Additionally, it includes homologous and heterologous sequences with a high degree of functional similarity.

Career Highlights

Anthony Trieu is currently employed at Dow Agrosciences LLC, where he continues to work on innovative solutions in agricultural science. His expertise in plant genetics and disease resistance has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Anthony has collaborated with notable colleagues, including Aaron Todd Woosley and Avutu Sambi Reddy. These collaborations have further enhanced his research and development efforts in plant biotechnology.

Conclusion

Anthony Trieu's contributions to plant disease resistance through his innovative patent demonstrate his commitment to advancing agricultural science. His work not only addresses critical challenges in crop health but also paves the way for future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…